CONTENTS:
- Drugs in prisons: Exploring use, control, treatment and policy [Editorial]. Kolind T., Duke K., p. 89-92.
- Use of hierarchical cluster analysis to classify prisons in Ireland into mutually exclusive drug-use risk categories. Codd M., Mehegan J., Kelleher C., Drummond A., p. 93-98.
- The perceived and actual consequences of intranasal administration of buprenorphine or burprenorphine–naloxone by prisoners. Mohammed Z., Hughes G.J., Hearty P., Wright N.M.J., p. 99-102.
- Prison-based needle and syringe programmes (PNSP) - Still highly controversial after all these years. Stover H., Hariga F., p. 103-112.
- Views of Iranian prison staff towards needle-exchange program in prison. Shahbazi M., Moazen B., Rezaei F., Shokoohi M., Farnia M., Moradi G., et al., p. 113-119.
- Meeting the needs of prisoners with a drug or alcohol problem: No mean feat. McKeganey N., Russell C., Hamilton-Barclay T., Barnard M., Page G., Lloyd C., et al., p. 120-126.
- Provision of harm reduction and drug treatment services in custodial settings - Findings from the European ACCESS study. Zurhold H., Stover H., p. 127-134.
- Three enactments of drugs in Danish prison drug treatment: Illegal drugs, medicine and constrainers. Kolind T., Holm K., Duff C., Frank V.A., p. 135-143.
- "There's that many people selling it": Exploring the nature, organisation and maintenance of prison drug markets in England. Tompkins C.N.E., p. 144-153.
- Exploring prison drug use in the context of prison-based drug rehabilitation. Mjaland K., p. 154-162.
- In their own voices: Breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine. Mazhnaya A., Bojko M.J., Marcus R., Filippovych S., Islam Z., Dvoriak S., et al., p. 163-175.
- Findings from mixed-methods feasibility and effectiveness evaluations of the "Breaking Free Online" treatment and recovery programme for substance misuse in prisons. Elison S., Weston S., Davies G., Dugdale S., Ward J., p. 176-185.